← Back to Search

Guided Meditation + Aromatherapy for Anxiety

N/A
Recruiting
Led By Meredith D'Anna
Research Sponsored by NYU Langone Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 10-15 minutes prior to injection, 5 minutes post-injection (day 1)
Awards & highlights

Study Summary

This trial will study if a guided meditation plus an Elequil Aromatab can reduce pre-injection anxiety in orthopedic patients.

Who is the study for?
This trial is for adult English-speaking patients at NYU Langone's specific clinics, who are scheduled to receive an intra-articular injection and have consented to that treatment. It aims to help those experiencing anxiety or pain associated with these injections.Check my eligibility
What is being tested?
The study examines if guided meditation alone (Group A) or combined with aromatherapy using an Elequil Aromatab (Group B) before the injection can reduce anxiety compared to standard nursing care (Control Group C). Participants are randomly placed into one of these three groups.See study design
What are the potential side effects?
Since this trial involves non-invasive interventions like guided meditation and aromatherapy, side effects may be minimal but could include potential allergic reactions to the aromatherapy product.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~10-15 minutes prior to injection, 5 minutes post-injection (day 1)
This trial's timeline: 3 weeks for screening, Varies for treatment, and 10-15 minutes prior to injection, 5 minutes post-injection (day 1) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Blood Pressure
Change in Heart Rate
Change in Pain Score
+1 more

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: Experimental Group BExperimental Treatment2 Interventions
Participants in Group B will receive an Elequil Aromatab and the same guided meditation delivered to Group A prior to receiving the intra-articular injection.
Group II: Experimental Group AExperimental Treatment1 Intervention
Participants in Group A will receive a guided meditation prior to receiving the intra-articular injection.
Group III: ControlActive Control1 Intervention
Participants in the control arm will receive the current standard of nursing care for treating anxiety prior to receiving the intra-articular injection (emotional support, distraction, and/or therapeutic touch as necessary).
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Guided Meditation
2021
N/A
~400

Find a Location

Who is running the clinical trial?

NYU Langone HealthLead Sponsor
1,369 Previous Clinical Trials
840,538 Total Patients Enrolled
8 Trials studying Anxiety
752 Patients Enrolled for Anxiety
Meredith D'AnnaPrincipal InvestigatorNYU Langone Health

Media Library

Experimental Group A Clinical Trial Eligibility Overview. Trial Name: NCT05832983 — N/A
Anxiety Research Study Groups: Control, Experimental Group A, Experimental Group B
Anxiety Clinical Trial 2023: Experimental Group A Highlights & Side Effects. Trial Name: NCT05832983 — N/A
Experimental Group A 2023 Treatment Timeline for Medical Study. Trial Name: NCT05832983 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there new opportunities for volunteers to join this experiment?

"This research project is not currently recruiting, with the initial posting and latest update being on the 1st of May 2023 and 17th April 2023 respectively. Despite this, according to clinicaltrials.gov's records there are 431 other active trials that require participants at this point in time."

Answered by AI
~0 spots leftby May 2024